High-risk transient ischemic attack

Clinical trials for High-risk transient ischemic attack explained in plain language.

Never miss a new study

Get alerted when new High-risk transient ischemic attack trials appear

Sign up with your email to follow new studies for High-risk transient ischemic attack, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 2 Not yet finished but already full! 1 Completed 1

New pill aims to cut stroke risk without the bleeding worry

Disease control Ongoing

This large Phase 3 study tests whether milvexian, an experimental oral blood thinner, can prevent another stroke in people who recently had a mild stroke or a high-risk mini-stroke (TIA). Over 12,500 participants are randomly assigned to receive either milvexian or a placebo, alo…

Matched conditions: HIGH-RISK TRANSIENT ISCHEMIC ATTACK

Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control

Last updated Aug 30, 2026 00:00 UTC

High-risk transient ischemic attack

Get alerted when new High-risk transient ischemic attack trials appear

New pill aims to cut stroke risk without the bleeding worry